We have reassessed our ratings for wide-moat Microchip Technology, given the company’s surprise CEO transition and near-term guidance cut. We are lowering our fair value estimate to $75 from $81 as we model lower long-term gross margins and operating margins on a midcycle basis. We raise our Morningstar Uncertainty Rating to High from Medium based on greater volatility around the business and the stock price. We are also cutting our Capital Allocation Rating for Microchip to Standard from Exemplary, mostly because of missteps associated with inventory management rather than an indictment on the current management team or its roadmap for the year ahead. We maintain our wide moat rating but acknowledge that this rating is more debatable now than we would have thought a few months ago, given the severe drop in profitability during this latest downturn. Despite these rating adjustments, we still view the recent selloff as a bit overdone, and shares are attractively priced for long-term, patient investors willing to ride out the turnaround.